Fintel reports that on March 10, 2026, Citigroup upgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Sell to Neutral.
Analyst Price Forecast Suggests 27.68% Upside
As of February 25, 2026, the average one-year price target for Hims & Hers Health is $30.00/share. The forecasts range from a low of $13.13 to a high of $63.00. The average price target represents an increase of 27.68% from its latest reported closing price of $23.50 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Hims & Hers Health is 1,205MM, a decrease of 48.67%. The projected annual non-GAAP EPS is -0.20.
What is the Fund Sentiment?
There are 605 funds or institutions reporting positions in Hims & Hers Health. This is an decrease of 329 owner(s) or 35.22% in the last quarter. Average portfolio weight of all funds dedicated to HIMS is 0.18%, an increase of 39.00%. Total shares owned by institutions decreased in the last three months by 21.68% to 186,607K shares. 
The put/call ratio of HIMS is 0.59, indicating a bullish outlook.
What are Other Shareholders Doing?
Jpmorgan Chase holds 18,838K shares representing 8.58% ownership of the company. In its prior filing, the firm reported owning 17,786K shares , representing an increase of 5.59%. The firm decreased its portfolio allocation in HIMS by 36.46% over the last quarter.
Capital World Investors holds 14,323K shares representing 6.52% ownership of the company. In its prior filing, the firm reported owning 18,783K shares , representing a decrease of 31.14%. The firm decreased its portfolio allocation in HIMS by 56.54% over the last quarter.
Goldman Sachs Group holds 10,347K shares representing 4.71% ownership of the company. In its prior filing, the firm reported owning 9,224K shares , representing an increase of 10.86%. The firm decreased its portfolio allocation in HIMS by 35.28% over the last quarter.
Geode Capital Management holds 5,510K shares representing 2.51% ownership of the company. In its prior filing, the firm reported owning 4,901K shares , representing an increase of 11.05%. The firm decreased its portfolio allocation in HIMS by 66.03% over the last quarter.
Renaissance Technologies holds 4,818K shares representing 2.19% ownership of the company. In its prior filing, the firm reported owning 9,097K shares , representing a decrease of 88.81%. The firm decreased its portfolio allocation in HIMS by 64.37% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
